# Dendritic Cell-immunotherapy for Advanced Hepatocellular Carcinoma

> **NCT07726329** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Chang Gung Memorial Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Liver Neoplasms

## Interventions

- **BIOLOGICAL:** dendritic cells

## Key facts

- **NCT ID:** NCT07726329
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-07-01
- **Primary completion:** 2028-02
- **Final completion:** 2028-02
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07726329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07726329, "Dendritic Cell-immunotherapy for Advanced Hepatocellular Carcinoma". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07726329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*